definiens: means ( a ) with respect to Products in each Licens ed Field, the plans for the execution of certain research, develo pment, regulatory and manufacturing activities which the Parties have all ocated between them with respect to such Products in such Licensed Field during the Collaboration Term as described in Parts 2 through 4 of Schedule 1.12, and also ( b ) with respect to activities directed to [ * * ] for vaccines which activities are directed to Products in the Licensed Fields but not specific to Products in any particular Lice nsed Field and such other activities as described in Part 1 of Schedule 1.12 ( ), which plan provides for the execution of such activities which the Parties have allocated between them during the Collaboration Term . An init ial Collaboration Plan for each Licensed Field and for the Vaccine Platform Develop ment is attached hereto as Schedule 1.12 ( Collaboration Plan ) . The Parties sha ll update the Collaboration Plans annually in accordance with Section 3.1.2.2 . Notwithstanding the foregoing, the Parties agree that the Collaboration Plan for t he Licensed Field of SARS - CoV-2 shall be limited to discovery and pre - clinical rese arch and any responsibilities to conduct activities directed to clinical development or commercialization of a Product directed to SARS - CoV-2 shall be by mutual agreement of the Parties in a separate amendment to the Agreement